Trial Profile
A Study to Evaluate the Efficacy and Tolerability of Perampanel in Patients With Drug Resistant Myoclonic Epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2016 New trial record